This study was a triple-blind clinical trial. The statistical society included all pregnant women that referred to prenatal clinic of Rasoul Akram Hospital who had moderate to severe degree of skin itching, due to the visual analogue scale (VAS). On the basis of pilot sampling, to determine 2.5 unit difference in score average after the treatment of itching and estimate 2.5 unit standard deviation and considering 90% power and 95% confidence level and 30% loss coefficient, 90 subjects were calculated for samples (45 subjects in each group). Samples were chosen by availability sampling. Then, a simple random sampling was used and the subjects were divided into two groups of Case (peppermint oil) and Control (placebo).
In order to prepare peppermint oil and placebo, we coordinated with Shahid Beheshti School of Pharmacy in Tehran. Drugs were prepared under the supervision of pharmacognosist of the school. At first, peppermint oil has been prepared from Zardband Company (Tehran, Zardband) in May 2010. Then, 0.5% solutions of the oil were provided on sesame oil. Sesame oil was bought from certain groceries of markets in Tehran. Present solutions were prepared at amount of 60 mL in each dark glassy bottle. Each bottle was devoted a code, but all bottles were packed similarly. Furthermore, in order to be secure of menthol effective existence in pharmaceutical samples that are made, pharmaceutical analysis has done by related specialist. While we got the licensee, we referred to prenatal clinic of above mentioned hospital, the pregnant women who were affected by moderate or severe skin itching according to VAS and their tendency to participate at this research we started studying. Then, the questionnaire containing the recorded demographic characteristics and analyzed extent of itching in comparison with visual Analogue scale (VAS) was completed by researcher. VAS is a kind of system which evaluates the severity of itching and pain and is classified in groups such as: 8-10 severe score 4-7 moderate score 1-3 mild score
Inclusion criteria
Participants: were second or third trimester; had pruritus just in pregnancy; had pruritus without rash or eczema; did not have any physical or psychological diseases; had moderate to severe pruritus on the base of VAS; did not have any priority of allergy.
Exclusion criteria
Participants: Affected by any physical or psychological diseases during the study; Used any additional itching medication (drug or non-drug) to relief the pruritus; Used the advised drugs less than 10 days; Had presentation of rash or eczema during study.
At first, 110 subjects who had inclusion criteria were put under the study. In case group, a glassy bottle of 60 mL, 0.5% peppermint oil on the base of sesame oil was given to each sample and in the control group, 60 mL of sesame oil was given in a glassy bottle with similar package and coding.
It should be mentioned that according to the kind of research (a triple-blind clinical trial) the researcher, research units and statistician weren’t aware of what kind of drugs were used by patients. They should use the drug as topical and twice a day for the area which was affected by skin itching. Two weeks later, researching units have been evaluated for the severity of skin itching by means of VAS.
At last, 96 subjects remained and 49 of them were accidentally put into placebo consumer group and 47 of them in consumer of peppermint oil group.
All data analysis was being performed in SPSS. In order to describe subject’s data, two statistic methods of descriptive and analytic were used. Descriptive methods including frequency distribution table, mean index and standard deviation were applied to describe the characteristics of people who were under the study. To compare the severity of itching between the case and control groups, the independent t-test was used and to compare the situation before and after the intervention in groups, paired t-test, and for quality comparison of severity of itching, the Qui-square test was used.